Form 4 holding
CHIEF EXECUTIVE OFFICER, Director
ImmunoGen, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- $897,750
- Report date
- 12 Feb 2024
- Price
- $4.56
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount